Fructose 1,6-bisphosphatase 1 is a potential biomarker affecting the malignant phenotype and aerobic glycolysis in glioblastoma
Background Fructose 1,6-bisphosphatase 1 (FBP1) has been considered as a potential prognostic biomarker in glioblastoma (GBM), and this study explored the underlying mechanism. Methods The expression and effect of FBP1 expression on the prognosis of GBM patients were examined applying bioinformatics...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2025-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/18926.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|